Skip to main content
PMC home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1995 May;2(3):297–301. doi: 10.1128/cdli.2.3.297-301.1995

Connective tissue mast cells exhibit time-dependent degranulation heterogeneity.

M S Kaminer 1, G F Murphy 1, B Zweiman 1, R M Lavker 1
PMCID: PMC170149  PMID: 7664175

Abstract

Previous studies have identified two ultrastructurally distinct forms of mast cell (MC) degranulation following activation. Immunoglobulin E (IgE)-mediated reactions are characterized by a very rapid swelling and fusion of MC granules and abrupt mediator release. In certain chronic disease states (e.g., bullous pemphigoid), there is "piecemeal" degranulation with a more-gradual mediator release effected by microvesicular transport of "pieces" of granules to the cell surface. It is unclear whether these two degranulation patterns are determined by the different natures of the stimuli, heterogeneity among responding MC granules, or temporal factors. To investigate these issues, we have carried out electron microscopic studies with skin biopsies obtained from ragweed-sensitive subjects 15 and 30 s and 1, 3, 5, and 10 min after intradermal ragweed injection. "Anaphylactic"-type granule changes began by 15 s after ragweed injection and were complete by 5 min; unaffected granules were juxtaposed with granules that were swollen and fused. The remaining granules subsequently underwent changes in appearance similar to those seen in piecemeal degranulation. However, microvesicular transport of granule components to the surface was not observed. These findings indicate that skin MC changes in sites of IgE-mediated reactions include not only the typical very rapid anaphylactic degranulation but also a slower onset of gradual alteration of other granules, frequently within the same MC. These different patterns could reflect MC granule heterogeneity with attendant different responses to IgE-mediated stimuli.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkins P. C., Schwartz L. B., Adkinson N. F., von Allmen C., Valenzano M., Zweiman B. In vivo antigen-induced cutaneous mediator release: simultaneous comparisons of histamine, tryptase, and prostaglandin D2 release and the effect of oral corticosteroid administration. J Allergy Clin Immunol. 1990 Sep;86(3 Pt 1):360–370. doi: 10.1016/s0091-6749(05)80099-5. [DOI] [PubMed] [Google Scholar]
  2. Dvorak A. M., Hammond M. E., Morgan E., Orenstein N. S., Galli S. J., Dvorak H. F. Evidence for a vesicular transport mechanism in guinea pig basophilic leukocytes. Lab Invest. 1980 Feb;42(2):263–276. [PubMed] [Google Scholar]
  3. Dvorak A. M., Mihm M. C., Jr, Dvorak H. F. Degranulation of basophilic leukocytes in allergic contact dermatitis reactions in man. J Immunol. 1976 Mar;116(3):687–695. [PubMed] [Google Scholar]
  4. Dvorak A. M., Mihm M. C., Jr, Osage J. E., Kwan T. H., Austen K. F., Wintroub B. U. Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient. J Invest Dermatol. 1982 Feb;78(2):91–101. doi: 10.1111/1523-1747.ep12505711. [DOI] [PubMed] [Google Scholar]
  5. Dvorak A. M., Schleimer R. P., Schulman E. S., Lichtenstein L. M. Human mast cells use conservation and condensation mechanisms during recovery from degranulation. In vitro studies with mast cells purified from human lungs. Lab Invest. 1986 Jun;54(6):663–678. [PubMed] [Google Scholar]
  6. Dvorak A. M., Schulman E. S., Peters S. P., MacGlashan D. W., Jr, Newball H. H., Schleimer R. P., Lichtenstein L. M. Immunoglobulin E-mediated degranulation of isolated human lung mast cells. Lab Invest. 1985 Jul;53(1):45–56. [PubMed] [Google Scholar]
  7. Friedman M. M., Kaliner M. Ultrastructural changes in human skin mast cells during antigen-induced degranulation in vivo. J Allergy Clin Immunol. 1988 Dec;82(6):998–1005. doi: 10.1016/0091-6749(88)90136-4. [DOI] [PubMed] [Google Scholar]
  8. Galli S. J., Dvorak A. M., Dvorak H. F. Basophils and mast cells: morphologic insights into their biology, secretory patterns, and function. Prog Allergy. 1984;34:1–141. [PubMed] [Google Scholar]
  9. Kaminer M. S., Lavker R. M., Walsh L. J., Whitaker D., Zweiman B., Murphy G. F. Extracellular localization of human connective tissue mast cell granule contents. J Invest Dermatol. 1991 Jun;96(6):857–863. doi: 10.1111/1523-1747.ep12475169. [DOI] [PubMed] [Google Scholar]
  10. Kawanami O., Ferrans V. J., Fulmer J. D., Crystal R. G. Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab Invest. 1979 Jun;40(6):717–734. [PubMed] [Google Scholar]
  11. Lloyd A. G., Bloom G. D., Balazs E. A., Haegermark O. Combined biochemical and morphological ultrastructure studies on mast-cell granules. Biochem J. 1967 Jun;103(3):75P–76P. [PMC free article] [PubMed] [Google Scholar]
  12. Shalit M., Schwartz L. B., Golzar N., vonAllman C., Valenzano M., Fleekop P., Atkins P. C., Zweiman B. Release of histamine and tryptase in vivo after prolonged cutaneous challenge with allergen in humans. J Immunol. 1988 Aug 1;141(3):821–826. [PubMed] [Google Scholar]
  13. Ting S., Dunsky E. H., Lavker R. M., Zweiman B. Patterns of mast cell alterations and in vivo mediator release in human allergic skin reactions. J Allergy Clin Immunol. 1980 Nov;66(5):417–423. doi: 10.1016/0091-6749(80)90122-0. [DOI] [PubMed] [Google Scholar]
  14. Walsh L. J., Lavker R. M., Murphy G. F. Determinants of immune cell trafficking in the skin. Lab Invest. 1990 Nov;63(5):592–600. [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES